Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers

Conditions:   Acute Myeloid Leukemia;   Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Blasts 10 Percent or Less of Bone Marrow Nucleated Cells;   High Risk Myelodysplastic Syndrome;   Myeloid Sarcoma;   Myeloproliferative Neoplasm;   Philadelphia Chromosome Positive Interventions:   Drug: Cladribine;   Drug: Cytarabine;   Drug: Dexrazoxane Hydrochloride;   Drug: Gemtuzumab Ozogamicin;   Drug: Idarubicin Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials